NBDC Research ID: hum0299.v1

 

SUMMARY

Aims: Whole genome sequencing using the newly available PromethION Q20 platform (Nanopore) to validate haplotype phasing analysis

Methods: Whole genome sequencing using the PromethION Q20 platform (Nanopore)

Participants/Materials: Healthy white B-Lymphocyte cell line HG002 (NA24385)

 

Dataset IDType of DataCriteriaRelease Date
DRA012759 NGS (WGS) Unrestricted-access 2022/09/15

*Release Note

*When the research results including the data which were downloaded from NHA/DRA, are published or presented somewhere, the data user must refer the papers which are related to the data, or include in the acknowledgment. Learn more

 

MOLECULAR DATA

DRA012759

Participants/Materials Healthy white B-Lymphocyte cell line HG002 (NA24385): 1 sample
Targets WGS
Target Loci for Capture Methods -
Platform Nanopore [PromethION]
Library Source DNAs extracted from healthy white B-Lymphocyte cell line HG002 (NA24385)
Cell Lines HG002 (NA24385, Coriell Institute)
Library Construction (kit name) SQK-Q20EA
Fragmentation Methods -
Spot Type Single-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 11,990 bp
DDBJ Sequence Read Archive ID DRA012759
Total Data Volume 5.7 GB (fastq)
Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Yutaka Suzuki

Affiliation: Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo

Project / Group Name: -

Funds / Grants (Research Project Number):

NameTitleProject Number
KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas Identification of novel driver genes by whole genome sequencing of early stage lung tumors 20H00545
KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas Integrative analysis of structural variants and DNA methylation statuses in lung cancer genomes using long read sequencing 21J13203
KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas Platform for Advanced Genome Science 16H06279
Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED) Stratification of cancer patients by novel genomic aberrations using long-read sequencing technologies JP21cm0106582
Project for Cancer Research and Therapeutic Evolution (P-CREATE), Japan Agency for Medical Research and Development (AMED) Understanding the diversity of lung cancer genomic mutations induced by passive smoking and formulating therapeutic strategies JP21cm0106577

 

PUBLICATIONS

TitleDOIDataset ID
1 Phasing analysis of lung cancer genomes using a long read sequencer doi: 10.1038/s41467-022-31133-6 DRA012759
2